Webinar: ACR/CHEST ILD Guidelines in Practice| Video: All the Lonely People

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Our Interdisciplinary Outlook

Sherine Gabriel, MD, and Pamela Degotardi, PhD  |  

Rheumatologists and health professionals working together is one of our great strengths

Reading Rheum

David G. Borenstein, MD  |  

Handpicked Reviews of Contemporary Literature

Make a Difference by the End of Summer: Contact Congress

  |  

The more personal your contact with your elected officials, the more effective it will be. Although a personal discussion with a member of Congress is positive, a meeting or telephone conversation with one of his or her staff is just as valuable.

Within Our Reach–Funded Research Finds Highly Specific Markers of RA

  |  

A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.

Doused in Denmark

David S. Pisetsky, MD, PhD  |  

EULAR captured the complex picture of rheumatology’s future

Productive Partnership

Sherine Gabriel, MD, and Leslie J. Crofford, MD  |  

The ACR and the REF work closely to support the future of rheumatology